Cost-effectiveness analysis of bortezomib in combination...

Cost-effectiveness analysis of bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP) in patients with previously untreated mantle cell lymphoma

van Keep, Marjolijn, Gairy, Kerry, Seshagiri, Divyagiri, Thilakarathne, Pushpike, Lee, Dawn
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-016-2633-2
Date:
December, 2016
File:
PDF, 1.03 MB
english, 2016
Conversion to is in progress
Conversion to is failed